| Request a sample from "The Infoshop", another service of Global Information.
|
SUMMARY
Companion animals now account for one-third of the world market for animalhealth products. Sales were $4.5 billion in 2003 and Animal Pharm Reportsforecast that they will rise to $5.9 billion by the end of the decade. Thesector attracts the bulk of R&D investment, and there is a range of newproducts in companies\' development pipelines. At the same time, market leadingproducts will come off-patent, and generics companies are already planninglaunches of competitor brands. This report analyses all aspects of this highly dynamic market, including: - Market sizes and profiles in the 10 leading national markets, accountingfor 85% of the world market
- Reviews of product sectors, including the products on the market, recentdevelopments, generic activity and future prospects
- Market drivers, including investments in R&D, the next generation ofgeneric products and regulatory developments
- Profiles of the 10 leading companion animal companies, accounting fortwo-thirds of world sales
- The most important companion animal health problems.
Executive Summary:Products for use in companion animals have been the main driver of growth inan otherwise flat market for veterinary medicines over the past decade. Thisreport analyses the size and structure of the companion animal market,identifies major product segments and the geographical spread of sales in thesector, and profiles the businesses of leading companies involved in the market. Chapter 1 of the study provides a brief overview of major health problemsaffecting the three key companion animal species (dogs, cats and horses), andidentifies the type of products used to prevent, treat or control them. Viral,bacterial and parasitic infections are among the most prevalent challenges facedby companion animals. Chronic, often age-related, conditions such ascardiovascular disease and cancer are increasingly prevalent in dogs and cats,however, as the longevity of pets continues to rise, with cancer now the leadingdisease-related cause of mortality in the US canine population. Products used to prevent, treat or control disease in companion animals areaddressed in Chapter 2 of the report. The main focus of this section is productgroupings responsible for major shares of the companion animal market in valueterms, including antiparasitics, anti-infectives, anti inflammatories andbiologicals. Smaller segments in which significant launch activity has beenwitnessed recently or is expected in future are also addressed.
|
